Feed aggregator

New standards improve quality of donated prosthetic feet worldwide

Rss Feed - Thu, 05/14/2026 - 00:06
Researchers have proposed new standards into the decades' old prosthetic donations market, improving the quality of lower limb prosthetic feet by two-thirds – a major quality of life boost for recipients.

Four OICR-funded studies explore transformative approaches in cancer care

Rss Feed - Wed, 05/13/2026 - 23:59
Four new research studies funded by the Ontario Institute for Cancer Research (OICR) will deliver cutting-edge innovations by maximizing the impact of existing research and making the most out of patient contributions.

Sequential TACE after SBRT improves outcomes in recurrent hepatocellular carcinoma

Rss Feed - Wed, 05/13/2026 - 23:57
Comparative data on sequential transarterial chemoembolization (TACE) after stereotactic body radiation therapy (SBRT) in recurrent hepatocellular carcinoma (HCC) remain limited. This study aimed to evaluate the efficacy of this combination.

Qureight to support Mediar Therapeutics' Phase 2 trial of MTX-474 in diffuse cutaneous Systemic Sclerosis

Rss Feed - Wed, 05/13/2026 - 23:55
Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, and Mediar Therapeutics (Mediar), a clinical-stage biotechnology company advancing first-in-class therapies designed to halt fibrosis, today announced Qureight's AI-powered 3D quantitative imaging analytics platform and services will be used to support Mediar's Phase 2 EncompaSSc clinical trial.

Gene panel predicts chemotherapy response in triple-negative breast cancer

Rss Feed - Wed, 05/13/2026 - 22:51
Researchers at The University of Texas MD Anderson Cancer Center have characterized cancer cell-specific features in the tumor microenvironment (TME) of early-stage triple-negative breast cancer (TNBC) tissues, identifying specific macrophage subtypes associated with chemotherapy response.

Next-generation cancer therapy shows early promise as treatment candidate for glioblastoma

Rss Feed - Wed, 05/13/2026 - 22:17
A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for glioblastoma, the most aggressive and most common type of primary brain cancer in adults.

Air pollution linked to rising kidney disease hospitalization risks

Rss Feed - Wed, 05/13/2026 - 22:13
A study supported by FAPESP and published in the journal Scientific Reports showed a strong correlation between the concentration of particulate matter in the air of São Paulo, Brazil – primarily emitted by vehicle fuel combustion – and kidney disease.

Immune cell discovery reveals new pathway for hepatitis B treatment

Rss Feed - Wed, 05/13/2026 - 22:10
Fifteen years ago, doctors in Europe noticed a remarkable thing happening in people with chronic hepatitis B infections. When patients went off their medications, the virus started to come back - and then some of the patients were cured.

Obesity drugs and surgery linked to greater fat-free mass loss

Rss Feed - Wed, 05/13/2026 - 22:08
A new systematic review and meta-analysis of studies presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) shows that diet and exercise interventions result in a lower proportion of fat-free mass loss compared with obesity surgery or obesity drugs among people undergoing a weight loss of 10% or more.

Adult weight gain strongly linked to higher obesity-related cancer risk

Rss Feed - Wed, 05/13/2026 - 21:52
New research presented at this year's European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows that people who gain the highest amount of weight across adulthood are at greatly increased risk of certain obesity related cancers.

GLP-1 obesity drugs mainly reduce fat while preserving muscle mass

Rss Feed - Wed, 05/13/2026 - 21:50
New research to be presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) shows that following treatment with GLP-1 drugs for obesity, most weight loss is fat mass (80–85%) and relative muscle mass is preserved.

Tranexamic acid modestly reduces bleeding after cesarean delivery in women

Rss Feed - Wed, 05/13/2026 - 21:46
Giving tranexamic acid to women with placenta praevia (when the placenta covers the cervical opening) undergoing cesarean birth leads to a significant yet modest reduction in severe bleeding after delivery with no evidence of an increase in serious adverse events, finds a trial from China published by The BMJ today.

Study reveals hidden struggles faced by unaccompanied child refugees

Rss Feed - Wed, 05/13/2026 - 21:44
​From relentless cycles of intrusive memories to loneliness and physical pain - a new study form the University of East Anglia reveals the struggles of refugees who entered the UK as unaccompanied minors.

Brain-controlled hearing aid concept helps solve the cocktail party problem

Rss Feed - Wed, 05/13/2026 - 21:38
Researchers developed a real-time brain-controlled hearing system that uses neural signals to identify and amplify the speaker a listener is focusing on in noisy, multi-talker environments. Using intracranial brain recordings, the system improved speech intelligibility, reduced listening effort, tracked attention shifts, and provided a benchmark for future brain-guided hearing aids.

New trial aims to improve ATTR-CM diagnosis in heart failure

Rss Feed - Wed, 05/13/2026 - 21:36
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized yet frequently underdiagnosed cause of heart failure, particularly among older adults.

New mRNA adjuvant dramatically boosts T-cell vaccine responses in mice

Rss Feed - Wed, 05/13/2026 - 21:19
MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines - an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.

Wastewater monitoring may predict influenza outbreaks one week earlier

Rss Feed - Wed, 05/13/2026 - 21:08
Seasonal influenza can spread rapidly, and timely information on rising cases is essential for public health decisions and healthcare resource planning.

Pregnancy not linked to increased myasthenia gravis flare-up risk

Rss Feed - Wed, 05/13/2026 - 21:03
For female participants with myasthenia gravis, pregnancy is not associated with an increased risk of serious flare-ups of the disease, or new or worsening symptoms, according to a study published May 13, 2026, in Neurology, the medical journal of the American Academy of Neurology.

Immune-regulating molecule may offer new treatment approach for IBD patients

Rss Feed - Wed, 05/13/2026 - 20:58
Mayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, do not respond to commonly used therapies.

Why experts say PCOS needs a new name

Rss Feed - Wed, 05/13/2026 - 20:57
A Lancet Health Policy paper reports an international consensus process that selected polyendocrine metabolic ovarian syndrome (PMOS) as the new name for polycystic ovary syndrome (PCOS). The change aims to shift the focus away from ovarian cysts and better reflect the condition’s endocrine, metabolic, and ovarian features.

Pages